Newfeed

HONG KONG, Dec. 15, 2023 /PRNewswire/ — Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in patients with newly diagnosed higher-risk myelodysplastic syndrome (HR-MDS) and treatment-naïve acute myeloid

The annual conference provides tips to navigate spiritual, personal, and professional development, mental health, leadership, entrepreneurship, and much more ATLANTA, Dec. 15, 2023 /PRNewswire/ — Visionary futurist, thought leader, and global life and business strategist, Dr. Cindy Trimm, has

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: